Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2024-03-04 00:00:00 ET · period of report 2024-02-29 · accession 0001437749-24-006519 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-04 | 2024-02-29 | LMAT | Pellegrino Joseph P JR | CFO, Dir | M - OptEx | $36.17 | +33.9K | 21.7K | New | +$1.23M |
| DM | 2024-03-04 | 2024-02-29 | LMAT | Pellegrino Joseph P JR | CFO, Dir | S - Sale+OE | $69.76 | -37.0K | 6,452 | -85% | -$2.58M |
| D | 2024-03-04 | 2024-02-29 | LMAT | Pellegrino Joseph P JR | CFO, Dir | A - Grant | $0.00 | +2,649 | 9,099 | +41% | $0 |
| D | 2024-03-04 | 2024-02-29 | LMAT | Pellegrino Joseph P JR | CFO, Dir | F - Tax | $70.00 | -296 | 8,809 | -3% | -$20.7K |
| DM | 2024-03-04 | 2024-02-29 | LMAT | Pellegrino Joseph P JR | CFO, Dir | M - OptEx | $0.00 | -33.9K | 5,345 | -86% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-29 | M | A | 5,346 | $37.29 | 32,958 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 2 | Common | Common Stock | 2024-02-29 | M | A | 7,031 | $48.60 | 39,989 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 3 | Common | Common Stock | 2024-02-29 | M | A | 3,430 | $47.19 | 43,419 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 4 | Common | Common Stock | 2024-02-29 | S | D | 1,979 | $68.56 | 41,440 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $68.05 to $69.04. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. |
| 5 | Common | Common Stock | 2024-02-29 | S | D | 28,461 | $69.72 | 12,979 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $69.05 to $70.045. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. |
| 6 | Common | Common Stock | 2024-02-29 | S | D | 6,250 | $70.27 | 6,729 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $70.05 to $70.62. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. |
| 7 | Common | Common Stock | 2024-02-29 | S | D | 277 | $71.19 | 6,452 | D | — | — | |
| 8 | Common | Common Stock | 2024-02-29 | M | D | 2 | $0.00 | 6,450 | D | — | — | (F5) Represents shares from the release of fractional dividend equivalent rights returned to company. |
| 9 | Common | Common Stock | 2024-02-29 | A | A | 2,649 | $0.00 | 9,099 | D | — | — | (F6) These shares represent LMAT common stock acquired on February 29, 2024, upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022. The PSU award vests as follows: 25% upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next three years. (F7) Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals. |
| 10 | Common | Common Stock | 2024-02-29 | M | A | 6 | $0.00 | 9,105 | D | — | — | (F8) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. |
| 11 | Common | Common Stock | 2024-02-29 | F | D | 296 | $70.00 | 8,809 | D | — | — | (F9) These shares represent shares withheld by the issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. |
| 12 | Common | Common Stock | 2024-02-29 | M | A | 5,883 | $35.48 | 27,612 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 13 | Common | Common Stock | 2024-02-29 | M | A | 3,461 | $31.30 | 12,996 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 14 | Common | Common Stock | 2024-02-29 | M | A | 8,733 | $23.56 | 21,729 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 15 | Derivative | Stock Option (Right to Buy) | 2024-02-29 | M | D | 3,461 | $0.00 | 0 | D | $31.30 · 2017-12-22 to 2024-12-22 | 3,461 Common Stock | (F10) This option is fully vested and exercisable. |
| 16 | Derivative | Dividend Equivalent Rights | 2024-02-29 | M | D | 6.68 | $0.00 | 20.06 | D | — · — to — | 6.68 Common Stock | (F12) These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| 17 | Derivative | Stock Option (Right to Buy) | 2024-02-29 | M | D | 3,430 | $0.00 | 10,291 | D | $47.19 · 2022-12-12 to 2029-12-12 | 3,430 Common Stock | (F11) This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. |
| 18 | Derivative | Stock Option (Right to Buy) | 2024-02-29 | M | D | 7,031 | $0.00 | 7,030 | D | $48.60 · 2021-12-11 to 2028-12-11 | 7,031 Common Stock | (F11) This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. |
| 19 | Derivative | Stock Option (Right to Buy) | 2024-02-29 | M | D | 5,883 | $0.00 | 2,941 | D | $35.48 · 2019-12-20 to 2026-12-20 | 5,883 Common Stock | (F11) This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. |
| 20 | Derivative | Stock Option (Right to Buy) | 2024-02-29 | M | D | 8,733 | $0.00 | 0 | D | $23.56 · 2018-12-19 to 2025-12-19 | 8,733 Common Stock | (F10) This option is fully vested and exercisable. |
| 21 | Derivative | Stock Option (Right to Buy) | 2024-02-29 | M | D | 5,346 | $0.00 | 5,345 | D | $37.29 · 2020-12-02 to 2027-12-02 | 5,346 Common Stock | (F11) This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. |